More about our biomarkers for Rheumatoid Arthritis
Our blood-based tissue-derived biomarkers can quantify changes occurring in patients with SpA by reflecting the diagnostic status of the three key affected tissues; ankylosis (bone), fibrosis (connective tissue) and chronic inflammation, and thereby be one step closer to personalized medicine.
More about our biomarkers for Spondyloarthritis
Our non-invasive blood biomarkers have a lot of value to add for studies in osteoarthritis, and for safety studies where structural changes to the joint are necessary to monitor. Read more about how disease activity can be monitored with the aid of Nordic Bioscience biomarkers, or understand to a deeper extent how the pharmacodynamic modulation occurs.
More about our biomarkers for Osteoarthritis
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.
